Researchers screen dual main protease-cathepsin L inhibitors against SARS-CoV-2

By | June 15, 2021
In a recent study released on the bioRxiv* preprint server, a selective dual inhibitor of MPRO and cathepsin L is described, producing synergistic results that suppress SARS-CoV-2 infection.